Comparison of cholinesterase inhibitor safety in real-world practice

INTRODUCTION: Cholinesterase inhibitors (ChEIs) are widely used to treat mild to moderate Alzheimer's disease and related dementia. Clinical trials have focused on placebo comparisons, inadequately addressing within-class comparative safety. METHODS: New users of ChEIs in British Columbia were...

Descripción completa

Detalles Bibliográficos
Autores principales: Carney, Greg, Bassett, Ken, Wright, James M., Maclure, Malcolm, McGuire, Nicolette, Dormuth, Colin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944712/
https://www.ncbi.nlm.nih.gov/pubmed/31921965
http://dx.doi.org/10.1016/j.trci.2019.09.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944712/
https://www.ncbi.nlm.nih.gov/pubmed/31921965
http://dx.doi.org/10.1016/j.trci.2019.09.011

Ejemplares similares